K. Moriwaki, H. Komaba, S. Noto, S. Yanagisawa, et al, Cost-effectiveness of alendronate for the treatment of osteopenic postmenopausal women in Japan. Journal of Bone and Mineral Research. Volume 28, Issue 2, pp395-403,2013
H Nagase, K Moriwaki, M Kamae, S Yanagisawa, I Kamae, Cost-Effectiveness Analysis of Oseltamivir for Influenza Treatment Considering the Virus Emerging Resistant to the Drug in Japan, Value in Health,12（S3）,pp.S62-S65,2009．
G Chuluunkhuu, N Nakahara, S Yanagisawa, I Kamae. The efficacy of reboxetine as an antidepressant: a meta-analysis of both continuous (mean HAM-D score) and dichotomous (response rate) outcomes. Kobe J.Med.Sci.,Vol.54,No2, pp.149-158,2008.
M Otsuka, Y Akizuki, K Otsuka, S Yanagisawa, I Kamae, James A Jorgenson. A Comparison of the Technical Quality of American and Japanese Ranitidine Tablets. Dissolution Technologies, Vol.14(3), pp.22-28,2007
Takahashi K, Uchiyama H, Yanagisawa S, and Kamae I. The logistic regression and ROC analysis of group-based screening for predicting diabetes incidence in four years, Kobe J.Med.Sci., Vol.52,No.6,pp171-180,2006.
LI CAI, Uchiyama H, Yanagisawa S, and Kamae I. Cost-effectiveness Analysis of Influenza and Pneumococcal Vaccinations among Elderly People in Japan， Kobe J.Med.Sci., Vol.52,No.4,pp97-109,2006.
Yanagisawa S,Kamae I. Clinical Epidemiologic Evaluation of BSE Screening Tests in Japan. Kobe J.Med.Sci.,Vol.52,No.3, pp49-59,2006．
Inoue H,Yanagisawa S,Kamae I. Computer-Simulated Assessment of Methods for Transporting Severely Injured Individuals in Disaster- Case Study of Airport Accident. Computer Methods and Programs in Biomedicine 81, pp.256-265.2006.
Inoue H, Uchiyama H, Moriwaki K, Yanagisawa S, A Development of Visualization Software for a Bayesian Signal Detection Method. The 16th Annual Meeting of JSPE and the 5th ACPE Joint Meeting Abstracts, Page62, 2010,10.
Moriwaki K、 Kamae I、 Yanagisawa S、 Nagase H、A BAYESIAN ADAPTIVE DESIGN FOR EVALUATION OF THE GAP BETWEEN EFFICACY AND ERROR-ADJUSTED EFFECTIVENESS、ISPOR 10th Annual European Congress, 20-23 OCTOBER 2007．
Nagase H、Kamae M、Moriwaki K、Yanagisawa S、Kamae I、 COST-EFFECTIVENESS ANALYSIS OF OSELTAMIVIR FOR INFLUENZA IN JAPAN: MODELING IN THE VIRUS EMERGING RESISTANT TO THE DRUG、ISPOR 10th Annual European Congress, 20-23 OCTOBER 2007．
Yanagisawa S,Kamae I, Oderda GM,Otsuka M, Jorgenson J, Otsuka K,Brixner D. Outcomes and Costs of Generic and Trade Ranitidine Use in the United States and Japan. ISPOR 2nd Asia-Pacific Congress.2006.3
Shimaya M, Li C, Yanagisawa S,Kamae I. Pharmacoeconomic Evalutions Regarding Type-2 Diabetes in Asia-Pacific. ISPOR 2nd Asia-Pacific Congress.2006.3